Allergy & Immunology
COPD
More in COPD
Recent events highlight need for improvement and regulation
Social isolation may lead to fewer resources for managing the condition
Prices went down but reductions in new oxygen prescriptions and discontinuations were minimal
Living in polluted zip codes was linked to worse outcomes after transplant
There remains an unmet need for effective COPD therapies, expert says
Phase III trial program showed 30% to 34% reduction in moderate or severe exacerbations
However, treatment group crossovers muddied the waters in open-label Chinese trial
"We should be cautious about using drugs off-label," investigator says
They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert
An immediate appointment to a smoking cessation clinic shows benefit versus usual care
Propellants in metered-dose inhalers are the biggest culprit
"No race is spared, although people of color fare worse," says project leader
Health news and commentary gathered by 鶹ý staff
Nonphysician program linked to lower all- and specific-cause mortality risks
